| Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel A Henningsson, S Marsh, WJ Loos, MO Karlsson, A Garsa, K Mross, ... Clinical Cancer Research 11 (22), 8097-8104, 2005 | 242 | 2005 |
| A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma … BV Manyam, AA Garsa, RI Chin, CA Reddy, B Gastman, W Thorstad, ... Cancer 123 (11), 2054-2060, 2017 | 133 | 2017 |
| CYP3A4 and CYP3A5genotyping by Pyrosequencing AA Garsa, HL McLeod, S Marsh BMC medical genetics 6, 1-5, 2005 | 107 | 2005 |
| Pyrosequencing of clinically relevant polymorphisms S Marsh, CR King, AA Garsa, HL McLeod Pharmacogenomics: Methods and protocols, 97-114, 2005 | 71 | 2005 |
| Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy SN Badiyan, RC Rao, AJ Apicelli, S Acharya, V Verma, AA Garsa, ... International Journal of Radiation Oncology* Biology* Physics 88 (4), 801-805, 2014 | 59 | 2014 |
| Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma AA Garsa, AJ Chang, T DeWees, CR Spencer, DR Adkins, F Dehdashti, ... Journal of radiation oncology 2, 27-34, 2013 | 39 | 2013 |
| Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases AA Garsa, SN Badiyan, T DeWees, JR Simpson, J Huang, RE Drzymala, ... International Journal of Radiation Oncology* Biology* Physics 90 (2), 407-413, 2014 | 35 | 2014 |
| A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer AA Garsa, DJ Ferraro, TA DeWees, TL Deshields, JA Margenthaler, ... International Journal of Radiation Oncology* Biology* Physics 87 (5), 1043-1050, 2013 | 34 | 2013 |
| Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer AA Garsa, DJ Ferraro, T DeWees, JA Margenthaler, M Naughton, R Aft, ... Brachytherapy 12 (2), 99-106, 2013 | 34 | 2013 |
| Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous … MJ Xu, AA Lazar, AA Garsa, ST Arron, WR Ryan, IH El‐Sayed, JR George, ... Head & Neck 40 (7), 1406-1414, 2018 | 32 | 2018 |
| Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study AA Garsa, DJ Ferraro, T DeWees, JA Margenthaler, M Naughton, R Aft, ... International Journal of Radiation Oncology* Biology* Physics 85 (4), 965-970, 2013 | 32 | 2013 |
| Radiation therapy for brain metastases: A systematic review A Garsa, JK Jang, S Baxi, C Chen, O Akinniranye, O Hall, J Larkin, ... Practical radiation oncology 11 (5), 354-365, 2021 | 31 | 2021 |
| Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation DJ Ferraro, AA Garsa, TA DeWees, JA Margenthaler, M Naughton, R Aft, ... Radiation Oncology 7, 1-11, 2012 | 31 | 2012 |
| Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS) C Abraham, A Garsa, SN Badiyan, R Drzymala, D Yang, T DeWees, ... Advances in radiation oncology 3 (2), 146-153, 2018 | 29 | 2018 |
| Management of chordoma and chondrosarcoma with fractionated stereotactic radiotherapy HN Vasudevan, DR Raleigh, J Johnson, AA Garsa, PV Theodosopoulos, ... Frontiers in surgery 4, 35, 2017 | 26 | 2017 |
| Interaction between PPARA genotype and β-blocker treatment influences clinical outcomes following acute coronary syndromes S Cresci, PG Jones, CC Sucharov, S Marsh, DE Lanfear, A Garsa, ... Future Medicine Ltd 9 (10), 1403-1417, 2008 | 25 | 2008 |
| Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar … SN Badiyan, AJ Bierhals, JR Olsen, KM Creach, AA Garsa, T DeWees, ... Radiation Oncology 8, 1-7, 2013 | 21 | 2013 |
| Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer MJ Zhou, A van Zante, AA Lazar, ER Groppo, AA Garsa, WR Ryan, ... Head & Neck 40 (5), 904-916, 2018 | 16 | 2018 |
| Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian cancer: a feasibility study AA Garsa, RS Andrade, DE Heron, S Beriwal, H Kim, E Brandner, G Kuo, ... International Journal of Gynecologic Cancer 17 (1), 2007 | 16 | 2007 |
| Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging JM Floberg, TA DeWees, RI Chin, AA Garsa, F Dehdashti, B Nussenbaum, ... Head & Neck 40 (10), 2280-2287, 2018 | 13 | 2018 |
